6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Vanguard Launches BondBuilder™ Model Portfolio Suite
Just now	Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
Just now	Summit State Bank Earns $1,674,000, or $0.25 Per Diluted Share, in First Quarter 2026
1m ago	NetSuite Brings AI-Powered Speed and Precision to SuiteCloud Development
2m ago	BorgWarner Showcases Thermal, Power Electronics, Battery Solutions at Advanced Clean Transportation Expo 2026

About

Aquestive Therapeutics Inc (NASDAQ:AQST) — investor relations, events, news, and company updates on 6ix.

Latest News

Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Aquestive Therapeutics to Participate in Upcoming March Investor Conferences

Financials

Revenue

$44.55 M

Market Cap

$499.16 M

EPS

-0.78

Community Chat

Ask AI